Lehr Martin A.'s Form 4/A amendment
AmendedContext Therapeutics Inc. (CNTX) · filed Dec 17, 2021
- Accession no.
- 0001842952-21-000027
- Filed
- Dec 17, 2021
- Trade date
- Oct 22, 2021
- Filing delay
- 56 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Oct 22, 2021
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market purchases total $50.0K. It was filed 56 days after the trade.
This amendment replaces 0001179110-21-009609 (filed Oct 25, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lehr Martin A.CIK 0001861989 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2021 | Common Stock | OLess common codeAcquired | +52,680 | $7.14 | +$376,135.2 | 0 | Indirect | |
| Oct 22, 2021 | Common Stock | CConversionAcquired | +210,715 | –F1 | – | 210,715 | Indirect | |
| Oct 22, 2021 | Common Stock | CConversionAcquired | +586,475 | –F2 | – | 797,190 | Indirect | |
| Oct 22, 2021 | Common Stock | PPurchaseAcquired | +10,000 | $5.00 | +$50,000 | 807,190 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2021 | Common Stock | OLess common codeAcquired | +52,680 | $0.00 | $0 | 0 | Indirect | |
| Oct 22, 2021 | Common Stock | CConversionDisposed | −210,715 | –F1 | – | 7 | Indirect | |
| Oct 22, 2021 | Common Stock | CConversionDisposed | −586,475 | –F2 | – | 1 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.
- F2
Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.
- F3
Fully vested.
Remarks
The attached amends and restates the Form 4 filed on October 25, 2021 in its entirety